The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study

BACKGROUND: Hyperuricemia is a risk factor for the onset of chronic kidney disease (CKD) and is significantly associated with the progression of CKD. However, there is no sufficient evidence by interventional research supporting a cause-effect relationship. Hyperuricemic patients without gouty arthr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoya, Tatsuo, Kimura, Kenjiro, Itoh, Sadayoshi, Inaba, Masaaki, Uchida, Shunya, Tomino, Yasuhiko, Makino, Hirofumi, Matsuo, Seiichi, Yamamoto, Tetsuya, Ohno, Iwao, Shibagaki, Yugo, Iimuro, Satoshi, Imai, Naohiko, Kuwabara, Masanari, Hayakawa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899617/
https://www.ncbi.nlm.nih.gov/pubmed/24433285
http://dx.doi.org/10.1186/1745-6215-15-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899617/
https://www.ncbi.nlm.nih.gov/pubmed/24433285
http://dx.doi.org/10.1186/1745-6215-15-26

Ejemplares similares